FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 113 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 469.50 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,080,000 | +139.2% | 187,963 | +8.0% | 0.00% | 0.0% |
| Q4 2020 | $2,960,000 | +417.5% | 173,996 | +43.1% | 0.00% | – |
| Q3 2020 | $572,000 | -24.0% | 121,553 | -1.6% | 0.00% | – |
| Q2 2020 | $753,000 | +136.8% | 123,526 | -11.9% | 0.00% | – |
| Q1 2020 | $318,000 | -46.5% | 140,142 | +8.3% | 0.00% | – |
| Q4 2019 | $594,000 | -2.9% | 129,354 | -18.1% | 0.00% | – |
| Q3 2019 | $612,000 | -36.7% | 157,945 | -1.5% | 0.00% | – |
| Q2 2019 | $967,000 | -57.8% | 160,395 | -6.2% | 0.00% | -100.0% |
| Q1 2019 | $2,291,000 | +43.8% | 170,972 | -0.1% | 0.00% | – |
| Q4 2018 | $1,593,000 | -33.5% | 171,191 | -0.6% | 0.00% | -100.0% |
| Q3 2018 | $2,397,000 | -5.4% | 172,231 | +7.5% | 0.00% | 0.0% |
| Q2 2018 | $2,533,000 | -12.6% | 160,155 | -5.1% | 0.00% | 0.0% |
| Q1 2018 | $2,899,000 | -12.0% | 168,741 | +12.3% | 0.00% | 0.0% |
| Q4 2017 | $3,293,000 | -64.3% | 150,245 | -33.3% | 0.00% | -66.7% |
| Q3 2017 | $9,222,000 | +34.1% | 225,423 | -1.3% | 0.00% | +50.0% |
| Q2 2017 | $6,876,000 | -15.0% | 228,350 | +2.0% | 0.00% | 0.0% |
| Q1 2017 | $8,093,000 | -28.1% | 223,876 | -0.3% | 0.00% | -33.3% |
| Q4 2016 | $11,250,000 | +48.4% | 224,505 | +55.4% | 0.00% | +50.0% |
| Q3 2016 | $7,582,000 | +23.0% | 144,458 | -3.1% | 0.00% | 0.0% |
| Q2 2016 | $6,164,000 | +15.5% | 149,061 | +13.5% | 0.00% | 0.0% |
| Q1 2016 | $5,338,000 | +5.5% | 131,367 | +7.7% | 0.00% | 0.0% |
| Q4 2015 | $5,061,000 | +194.1% | 121,932 | +9.0% | 0.00% | +100.0% |
| Q3 2015 | $1,721,000 | -44.5% | 111,819 | -10.5% | 0.00% | 0.0% |
| Q2 2015 | $3,103,000 | +56.0% | 124,968 | +43.6% | 0.00% | 0.0% |
| Q1 2015 | $1,989,000 | +15.1% | 87,047 | +36.0% | 0.00% | – |
| Q4 2014 | $1,728,000 | +117.1% | 63,996 | -5.7% | 0.00% | – |
| Q3 2014 | $796,000 | -63.3% | 67,899 | -51.2% | 0.00% | – |
| Q2 2014 | $2,166,000 | +473.0% | 139,280 | +624.9% | 0.00% | – |
| Q1 2014 | $378,000 | +97.9% | 19,214 | +68.7% | 0.00% | – |
| Q4 2013 | $191,000 | – | 11,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |